The DOI matches its Crossref record.
Combined Cancer Photothermal-Chemotherapy Based on Doxorubicin/Gold Nanorod-Loaded Polymersomes
Open accessAbstract
Gold nanorods (GNRs) are well known in photothermal therapy based on near-infrared (NIR) laser absorption of the longitudinal plasmon band. Herein, we developed an effective stimulus system -- GNRs and doxorubicin co-loaded polymersomes (P-GNRs-DOX) -- to facilitate co-therapy of photothermal and chemotherapy. DOX can be triggered to release once the polymersomes are corrupted under local hyperthermic condition of GNRs induced by NIR laser irradiation. Also, the cytotoxicity of GNRs caused by the residual cetyltrimethylacmmonium bromide (CTAB) was reduced by shielding the polymersomes. The GNRs-loaded polymersomes (P-GNRs) can be efficiently taken up by the tumor cells. The distribution of the nanomaterial was imaged by IR-820 and quantitatively analyzed by ICP-AES. We studied the ablation of tumor cells in vitro and in vivo, and found that co-therapy offers significantly improved therapeutic efficacy (tumors were eliminated without regrowth.) compared with chemotherapy or photothermal therapy alone. By TUNEL immunofluorescent staining of tumors after NIR laser irradiation, we found that the co-therapy showed more apoptotic tumor cells than the other groups. Furthermore, the toxicity study by pathologic examination of the heart tissues demonstrated a lower systematic toxicity of P-GNRs-DOX than free DOX. Thus, the chemo-photothermal treatment based on polymersomes loaded with DOX and GNRs is a useful strategy for maximizing the therapeutic efficacy and minimizing the dosage-related side effects in the treatment of solid tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
Liu, Y., Bhattarai, P., Dai, Z., & Chen, X. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00618k · Cited by 2,904
Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics
Zou, L., Wang, H., He, B., Zeng, L., Tan, T., Cao, H., He, X., Zhang, Z., Guo, S., & Li, Y. (2016) · Theranostics · doi:10.7150/thno.14988 · Cited by 915
Gold Nanorods: The Most Versatile Plasmonic Nanoparticles
Zheng, J., Cheng, X., Zhang, H., Bai, X., Ai, R., Shao, L., & Wang, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00422 · Cited by 651
Xie, X., Liao, J., Shao, X., Li, Q., & Lin, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-04229-z · Cited by 462
Self-citationThe in vitro and in vivo toxicity of gold nanoparticles
Jia, Y.-P., Ma, B.-Y., Wei, X.-W., & Qian, Z.-Y. (2017) · Chinese Chemical Letters · doi:10.1016/j.cclet.2017.01.021 · Cited by 316
Self-citationLiao, J., Shi, K., Jia, Y., Wu, Y., & Qian, Z. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.01.006 · Cited by 181
Self-citationExploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy
Muntimadugu, E., Kommineni, N., & Khan, W. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.010 · Cited by 82
Physical‐, chemical‐, and biological‐responsive nanomedicine for cancer therapy
Liao, J., Jia, Y., Wu, Y., Shi, K., Yang, D., Li, P., & Qian, Z. (2020) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1581 · Cited by 67
Self-citationPhoto-Responsive Polymersomes as Drug Delivery System for Potential Medical Applications
Hou, W., Liu, R., Bi, S., He, Q., Wang, H., & Gu, J. (2020) · Molecules · doi:10.3390/molecules25215147 · Cited by 46
Beygi, M., Oroojalian, F., Hosseini, S. S., Mokhtarzadeh, A., Kesharwani, P., & Sahebkar, A. (2023) · Progress in Materials Science · doi:10.1016/j.pmatsci.2023.101209 · Cited by 32
Retracted
Metadata
- Authors
- Liao, J., Li, W., Peng, J., Yang, Q., Li, H., Wei, Y., Zhang, X., & Qian, Z.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2015
- Volume
- 5
- Issue
- 4
- Pages
- 345-356
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W2009597964
- Cited by
- 193
- References
- 0
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.